Analysts Mean recommendation for Lexicon Pharmaceuticals Inc. (LXRX) was 2.80: Is this the key time?

Let’s start up with the current stock price of Lexicon Pharmaceuticals Inc. (LXRX), which is $1.38 to be very precise. The Stock rose vividly during the last session to $1.4343 after opening rate of $1.42 while the lowest price it went was recorded $1.37 before closing at $1.42.

Recently in News on September 23, 2020, Lexicon Pharmaceuticals Reaches Agreements to Exchange Convertible Notes, Reduce Outstanding Indebtedness. Lexicon Has Reduced Its Outstanding Debt by Approximately 90% in Third Quarter 2020. You can read further details here

My Next COVID-19 Stock Alert Poised For Triple Digit Moves

Get Ready for my next COVID-19 stock idea. I have been very fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street catches on. Our goal for our members is to get our Alert’s first before the crowd.    

>> Sign Up Now to Get Name & Ticker Symbol of Next Triple-Digit Gainer <<


Lexicon Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $4.4700 on 01/16/20, with the lowest value was $1.3700 for the same time period, recorded on 10/20/20.

Lexicon Pharmaceuticals Inc. (LXRX) full year performance was -58.18%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Lexicon Pharmaceuticals Inc. shares are logging -74.11% during the 52-week period from high price, and 0.73% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.37 and $5.33.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1027450 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Lexicon Pharmaceuticals Inc. (LXRX) recorded performance in the market was -66.75%, having the revenues showcasing -28.50% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 151.80M, as it employees total of 184 workers.

Analysts verdict on Lexicon Pharmaceuticals Inc. (LXRX)

During the last month, 0 analysts gave the Lexicon Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 1.7744, with a change in the price was noted -0.5300. In a similar fashion, Lexicon Pharmaceuticals Inc. posted a movement of -27.75% for the period of last 100 days, recording 1,409,973 in trading volumes.

Lexicon Pharmaceuticals Inc. (LXRX): Technical Analysis

Raw Stochastic average of Lexicon Pharmaceuticals Inc. in the period of last 50 days is set at 1.74%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 3.39%. In the last 20 days, the company’s Stochastic %K was 18.08% and its Stochastic %D was recorded 27.21%.

Let’s take a glance in the erstwhile performances of Lexicon Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -66.75%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -25.81%, alongside a downfall of -58.18% for the period of the last 12 months. The shares increased approximately by -6.76% in the 7-day charts and went up by -11.54% in the period of the last 30 days. Common stock shares were lifted by -28.50% during last recorded quarter.

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free